Some products represent uncharted territory for a regulatory agency. When this occurs, even the largest organizations can struggle when a seemingly small problem becomes a major roadblock. Check out our latest case study and see how an analytical approach from an independent lab cleared the way for this well-known product.
With the successful submission of the additional data, the client was able to receive final approval of the product.
The value of your CRO is not about speed or even the latest lab equipment – but about the advantage that an experienced and consultative ally brings to the process. The pressure in the industry to qualify and advance potential drug candidates into the pipeline is more complex and demanding than ever before. Is your lab up to the challenge?